Modeled impact of the COVID-19 pandemic and associated reduction in adult vaccinations on herpes zoster in the United States

Modeled impact of the COVID-19 pandemic and associated reduction in adult vaccinations on herpes zoster in the United States

Due to COVID-19, vaccinations dropped in 2020 and 2021. We estimated the impact of reduced recombinant zoster vaccine (RZV) use on herpes zoster (HZ) cases, complications, and quality-adjusted life-year (QALY) losses among older adults. Various scenarios were compared with Markov models using data f...

Full description

Bibliographic Details
Main Authors: Desmond Curran, Elizabeth M. La, Ahmed Salem, David Singer, Nicolas Lecrenier, Sara Poston
Format: Article
Language:English
Published: Taylor & Francis Group 2022-01-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
covid-19
herpes zoster
shingles
postherpetic neuralgia
recombinant zoster vaccine
vaccine
immunization
public health
Online Access:http://dx.doi.org/10.1080/21645515.2022.2027196

Similar Items

Similar Items